Quick answers
- What is Yusimry?
- Yusimry is a brand name of Adalimumab-atto, a prescription medicine. The FDA NDC Directory lists 6 Yusimry products in 3 strengths and forms.
- Who makes Yusimry?
- Emerge Bioscience Pte Ltd holds the FDA application for Yusimry (BLA761216, approved December 17, 2021). 1 other company (repackagers or distributors) also list Yusimry products.
- Is there a generic or store brand of Yusimry?
- Yes. The FDA NDC Directory lists 10 other products with the same active ingredients, strength and form as a Yusimry product. Ask your pharmacist whether one is right for you.
- Has Yusimry been recalled?
- No recall linked to Yusimry products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Yusimry is
Each Yusimry product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Adalimumab-atto · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| adalimumab 40 mg/0.4 mL injection, solution (subcutaneous) | Yusimry | 4 products, 2 companies | — |
| adalimumab 40 mg/0.8 mL injection, solution (subcutaneous) | Yusimry | 2 products, 1 company | DailyMed |
| adalimumab 80 mg/0.8 mL injection, solution (subcutaneous) | Yusimry | 4 products, 2 companies | — |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Adalimumab-atto →
FDA approval
- BLA: Biologics License Application: how a biologic medicine (made from living cells) is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| BLA761216 | Emerge Bioscience Pte Ltd | December 17, 2021 | 6 |
Companies that list Yusimry
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Yusimry products.
- Meitheal Pharmaceuticals Inc.4 products
- Coherus BioSciences Inc2 products
Recalls
No recall linked to Yusimry products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.